Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH‐wildtype glioblastoma

OBJECTIVE: Accumulating evidence from recent molecular diagnostic studies has indicated the prognostic significance of various genetic markers for patients with glioblastoma (GBM). To evaluate the impact of such genetic markers on prognosis, we retrospectively analyzed the outcomes of patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Funakoshi, Yusuke, Hata, Nobuhiro, Takigawa, Kosuke, Arita, Hideyuki, Kuga, Daisuke, Hatae, Ryusuke, Sangatsuda, Yuhei, Fujioka, Yutaka, Sako, Aki, Umehara, Toru, Yoshitake, Tadamasa, Togao, Osamu, Hiwatashi, Akio, Yoshimoto, Koji, Iwaki, Toru, Mizoguchi, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124111/
https://www.ncbi.nlm.nih.gov/pubmed/33838014
http://dx.doi.org/10.1002/cam4.3860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124111/
https://www.ncbi.nlm.nih.gov/pubmed/33838014
http://dx.doi.org/10.1002/cam4.3860

Ejemplares similares